CSF3 and muscular dystrophy: Improved muscle regeneration and increases in survival rates are observed with exogenous G-CSF treatment in a mouse model of muscular dystrophy [77, 78], while the rodent model of amyotrophic lateral sclerosis (ALS) had improved motor function and 55% larger muscle fibres following G-CSF treatment [55].